Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4499103 | 0.84 | ELANE (0.53) | ELANEAKR1C3MAPTGAADRD2 | |
| SCHEMBL17718224 | 0.84 | ALDH1A1 (0.50) | ELANEAKR1C3MAPTALDH1A1TDP1 | |
| SCHEMBL933092 | 0.82 | KDM4E (0.58) | MAPTALDH1A1TDP1KDM4EHSD17B10 | |
| SCHEMBL9282306 | 0.80 | ELANE (0.61) | ELANEAKR1C3MAPTGAADRD2 | |
| SCHEMBL7896682 | 0.80 | MAPT (0.46) | ELANEAKR1C3MAPTGAAALDH1A1 | |
| SCHEMBL14961216 | 0.79 | HPGD (0.42) | ELANEAKR1C3ALDH1A1TDP1ATM | |
| SCHEMBL2857273 | 0.79 | ELANE (0.59) | ELANEAKR1C3MAPTGAADRD2 | |
| Cyclohexane SCHEMBL11130138 | 0.78 | KDM4E (0.53) | MAPTGAAALDH1A1TDP1KDM4E | |
| SCHEMBL11045026 | 0.78 | ELANE (0.54) | ELANEAKR1C3MAPTGAADRD2 | |
| SCHEMBL50229 | 0.77 | MAPT (0.64) | ELANEAKR1C3MAPTGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1427770-B1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GEN ELECTRIC (US) | 2005-01-19 | — | — | EP | claimed |
| EP-1427770-A1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2004-06-16 | — | — | EP | claimed |
| US-20030120025-A1 | Process for the production of polycarbonate | GENERAL ELECTRIC COMPANY | 2003-06-26 | — | — | US | claimed |
| WO-2003022905-A1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2003-03-20 | — | — | WO | claimed |
| US-6525163-B1 | Reducing static charge, improving heat aging, and lowering water absorption by increasing endcap levels | GENERAL ELECTRIC COMPANY | 2003-02-25 | — | — | US | claimed |
| US-20230321083-A1 | Inhibitors of GPR174 and Uses Thereof | OMEROS CORP (US) | 2023-10-12 | — | — | US | disclosed |
| CN-104588088-B | For preparing catalyst of 2 alkyl-anthraquinones and its preparation method and application | 中国石油化工股份有限公司 | 2017-03-01 | — | — | CN | disclosed |
| EP-1427770-B1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GEN ELECTRIC (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-1427770-A1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2004-06-16 | — | — | EP | disclosed |
| US-20030120025-A1 | Process for the production of polycarbonate | GENERAL ELECTRIC COMPANY | 2003-06-26 | — | — | US | disclosed |
| WO-2003022905-A1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2003-03-20 | — | — | WO | disclosed |
| US-6525163-B1 | Reducing static charge, improving heat aging, and lowering water absorption by increasing endcap levels | GENERAL ELECTRIC COMPANY | 2003-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321083-A1 | Inhibitors of GPR174 and Uses Thereof | GPR174, GPR4, GPR88 | ELANE 3365/4885AKR1C3 2090/4885MAPT 2149/4885 |
| US-20030120025-A1 | Process for the production of polycarbonate | RNGTT, CAPG, RPL30 | ELANE 1186/4885AKR1C3 1298/4885MAPT 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.